Inventor · disambiguated record
Michael J. Smith
Also filed as: SMITH MICHAEL · SMITH MICHAEL J · SMITH MICHAEL JOHN
15 granted patents·9 pending applications·140 citations·filing 1997–2023
92Inventor score
Files withBRISTOL MYERS SQUIBB CO9WYETH CORP3ASTRAZENECA AB2CABOT CORP1HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC1
Top patents by PatentIndex Score
24 records- 0192US7728027B2Process for synthesizing compounds useful for treating hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 1, 2010·44 cites·22 claims
- 0290US8377980B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Feb 19, 2013·22 cites·16 claims
- 0389US8293245B2Methods and compositions based on Shiga toxin type 1 proteinSMITH MICHAEL·Filed 2007·Granted Oct 23, 2012·6 cites·23 claims
- 0489US7521473B2Inhibitors of protein tyrosine phosphatase 1BWYETH CORP·Filed 2005·Granted Apr 21, 2009·23 cites·59 claims
- 0587US8969529B2Methods and compositions based on shiga toxin type 2 proteinO'BRIEN ALISON·Filed 2010·Granted Mar 3, 2015·20 cites·7 claims
- 0686US10899745B2Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 26, 2021·4 cites·2 claims
- 0783US8846058B2Shiga toxoid chimeric proteinsSMITH MICHAEL J·Filed 2007·Granted Sep 30, 2014·5 cites·12 claims
- 0882US12410254B2Treatment of cardiometabolic disease with inhibitors of type I interferon signallingASTRAZENECA AB·Filed 2023·Granted Sep 9, 2025·1 cites·11 claims
- 0976US9801931B2Methods and compositions based on Shiga toxin type 2 proteinHENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC·Filed 2015·Granted Oct 31, 2017·2 cites·6 claims
- 1064US2014023652A1Methods and compositions based on shiga toxin type 1 proteinJACKSON H M FOUND MILITARY MED·Filed 2013·Application pending·0 cites
- 1163US11623013B2Methods and compositions for deuterated biologicsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 11, 2023·0 cites·18 claims
- 1261US2009048286A1Inhibitors of Protein Tyrosine Phosphatase 1BWYETH CORP·Filed 2008·Application pending·0 cites
- 1356US2019099506A1Methods and compositions for deuterated biologicsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1453US2023075422A1Use of fucosylation inhibitor for producing afucosylated antibodyBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1552US2013101591A1Methods and compositions based on shiga toxin type 1 proteinMILITARY MEDICINE INC THE HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF·Filed 2012·Application pending·0 cites
- 1651US2005203081A1Inhibitors of protein tyrosine phosphatase 1BFiled 2005·Application pending·0 cites
- 1747US2023250053A1Process for synthesizing targeting moleculesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1847US2023250056A1Process for synthesizing lipidsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1945US12459904B2Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 4, 2025·0 cites·23 claims
- 2041US7674822B2PTP1b inhibitorsWYETH CORP·Filed 2005·Granted Mar 9, 2010·0 cites·65 claims
- 2141US6268407B1Compositions and articles of manufactureCABOT CORP·Filed 1999·Granted Jul 31, 2001·7 cites·23 claims
- 2240US6600030B2Delayed progression to aids by a missense allele of the CCR2 geneUS HEALTH·Filed 1998·Granted Jul 29, 2003·5 cites·9 claims
- 2340US2022162325A1Type i interferon-mediated disordersASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 2422US6245575B1Screening of agents for treatment of alzheimer's diseaseMEDICAL RES COUNCIL·Filed 1997·Granted Jun 12, 2001·1 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Michael J. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →